Related Experiment Video
Updated: Jan 13, 2026

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
Examining Medical Interventions in Older Adults with Limited Life Expectancy-Opportunities and Challenges for
Nancy L Schoenborn1, Anna S Beeber2, Vadim A Dukhanin3
1Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
De-implementing medical interventions in older adults with limited life expectancy requires careful consideration of patient preferences. Shifting from age-based to life expectancy-based decisions is crucial for appropriate care.
Area of Science:
- Gerontology
- Health Services Research
- Medical Ethics
Background:
- Medical intervention benefits and harms evolve with patient age, necessitating re-evaluation for appropriateness and patient alignment.
- Older adults with limited life expectancy often continue interventions where harms exceed benefits, highlighting a need for de-implementation strategies.
- Patient preferences and shared decision-making are key considerations in optimizing medical care for aging populations.
Purpose of the Study:
- To review opportunities and challenges in de-implementing medical interventions for older adults with limited life expectancy.
- To explore the critical role of patient preferences and shared decision-making in this de-implementation process.
- To identify research gaps at the intersection of de-implementation, shared decision-making, and aging.
Main Methods:
- Critical review of literature on de-implementation in older adults.
- Analysis of examples including cancer screening, polypharmacy, and end-of-life care.
- Examination of challenges related to behavioral change and decision-making frameworks.
Main Results:
- De-implementation is complex, involving shifts from age-based to life expectancy-based decision-making.
- Existing de-implementation frameworks lack patient preference integration, while shared decision-making frameworks do not address de-implementation specifics.
- Examples like cancer screening, polypharmacy, and end-of-life care illustrate de-implementation challenges in this demographic.
Conclusions:
- Significant research gaps exist concerning de-implementation, shared decision-making, and aging.
- De-implementation decisions should evaluate preference sensitivity, evidence strength, harm-benefit balance, and irreversibility.
- Integrating patient preferences into de-implementation frameworks is essential for patient-centered care in older adults.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Ethical Dilemmas II

